Login
Toggle navigation
Videos
Categories
Trending
Kathriena Greenwell, M.D. Bariatric Surgery (Weight-loss Surgery)
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
A fellowship-trained bariatric surgeon and a board certified general surgeon.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Crypto vs Traditional VC Firms|Sean Lippel,Partner,FinTech Collective
00:10:00
Michael Saylor, Chairman & CEO of MicroStrategy, Inc., speaks with Bloomberg's Joe Weisenthal at the Bloomberg Crypto Summit about cryptocurrency strategies.
00:10:00
Insights into Global Investment Strategy and Economic Trends | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
Charting Future Frontiers: Insights from the GF Analyst and Media Conference 2024 | Andreas Müller - CEO of Georg Fischer
00:00:00
Franck Mouthon, co-founder and CEO of Theranexus
00:10:00
Favorite and least favorite aspects of crypto|Aleks Larsen,General Partner,Blockchain Capital
00:10:00
Transforming Financial Insights: Innovations at swissQuant Group | Dr. Florian Herzog, CEO, swissQuant Group
00:10:00
Infrastructure Insights: Peter Meany on the Case for Listed Assets | Peter Meany – Head of Global Listed Infrastructure, First Sentier Investors
00:10:00
Bee Partners Used Crowdbotics to Become the Smartest Small VC in the Business|Tim Smith,Partner,Bee Partners
00:10:00
invests in consumer tech, media/entertainment, and fintech companies.|Alex Pall,Co-Founder & Partner,MANTIS Venture Capital
00:10:00
investment firm focused on unlocking unsung potential|Michael Basch,Founder, General Partner CEO,Atento Capital
00:00:00
Suzy Dilly, CEO, ValiRx